Satoshi Watanabe Selected Research

Myocardial Infarction

6/2019	Effect of carvedilol on heart rate response to cardiopulmonary exercise up to the anaerobic threshold in patients with subacute myocardial infarction.
1/2019	Effects of αβ-Blocker Versus β1-Blocker Treatment on Heart Rate Response During Incremental Cardiopulmonary Exercise in Japanese Male Patients with Subacute Myocardial Infarction.
9/2015	Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction.
2/2015	Impaired β-cell function attenuates training effects by reducing the increase in heart rate reserve in patients with myocardial infarction.
5/2011	Cardiac rehabilitation outcome following percutaneous coronary intervention compared to cardiac surgery.
1/2010	Age-related differences in physiologic and psychosocial outcomes after cardiac rehabilitation.
10/2007	Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
1/2007	Catheter-based transcoronary myocardial hypothermia attenuates arrhythmia and myocardial necrosis in pigs with acute myocardial infarction.
8/2006	Influence of autonomic nervous dysfunction characterizing effect of diabetes mellitus on heart rate response and exercise capacity in patients undergoing cardiac rehabilitation for acute myocardial infarction.
1/2006	The effects of unsupervised exercise training on physical activity and physiological factors after supervised cardiac rehabilitation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Watanabe Research Topics

Disease

61	Neoplasms (Cancer) 02/2024 - 01/2002
49	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 04/2010
23	Lung Neoplasms (Lung Cancer) 02/2024 - 09/2013
12	Myocardial Infarction 06/2019 - 08/2004
9	Inflammation (Inflammations) 11/2023 - 09/2006
9	Heart Failure 01/2023 - 10/2005
8	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2004
8	Infections 11/2023 - 10/2013
8	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023 - 01/2013
8	Disease Progression 01/2023 - 01/2018
8	Pneumonia (Pneumonitis) 01/2023 - 10/2016
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2022 - 11/2013
6	Asthma (Bronchial Asthma) 01/2023 - 01/2015
6	Ganglion Cysts (Ganglion) 01/2013 - 07/2003
5	Idiopathic Pulmonary Fibrosis 03/2024 - 02/2018
5	Carcinoma (Carcinomatosis) 04/2022 - 01/2002
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2021 - 01/2019
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 10/2006
4	Adenocarcinoma of Lung 02/2023 - 11/2013
4	Fibrosis (Cirrhosis) 06/2021 - 03/2005
4	Stomach Neoplasms (Stomach Cancer) 12/2017 - 01/2003
4	Osteonecrosis (Kienbock's Disease) 02/2016 - 09/2012
3	Brain Neoplasms (Brain Tumor) 04/2024 - 11/2019
3	Bronchiectasis 03/2024 - 01/2013
3	Cough 03/2024 - 08/2017
3	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 04/2015
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2024 - 02/2021
3	Wounds and Injuries (Trauma) 12/2023 - 01/2020
3	Sepsis (Septicemia) 11/2023 - 01/2018
3	Body Weight (Weight, Body) 11/2023 - 01/2016
3	Obstructive Sleep Apnea 09/2023 - 01/2023
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2017
3	Ulcerative Colitis 01/2023 - 01/2022
3	Vomiting 07/2021 - 09/2013
3	Bronchiolitis Obliterans 05/2021 - 02/2017
3	Dyspnea (Shortness of Breath) 05/2021 - 07/2016
3	Liver Diseases (Liver Disease) 01/2021 - 03/2018
3	Diarrhea 01/2021 - 07/2015
3	Respiratory Hypersensitivity 01/2020 - 01/2015
3	Melanoma (Melanoma, Malignant) 12/2017 - 01/2014

Drug/Important Bio-Agent (IBA)

20	ErbB Receptors (EGF Receptor)IBA 12/2023 - 01/2011
20	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2011
15	Proteins (Proteins, Gene)FDA Link 02/2023 - 12/2002
10	Immune Checkpoint InhibitorsIBA 01/2024 - 12/2017
9	osimertinibIBA 12/2023 - 01/2019
9	PlatinumIBA 01/2023 - 12/2015
8	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 03/2016
8	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 08/2004
7	LigandsIBA 01/2023 - 01/2005
7	Gefitinib (Iressa)FDA Link 06/2021 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2008
6	AfatinibIBA 01/2022 - 12/2015
5	AntibodiesIBA 02/2024 - 08/2016
5	Gemcitabine FDA Link 12/2023 - 06/2011
5	Pemetrexed (MTA)FDA Link 01/2023 - 01/2018
5	alectinibIBA 12/2022 - 01/2017
5	Bevacizumab (Avastin)FDA Link 12/2022 - 01/2019
5	Anaplastic Lymphoma KinaseIBA 12/2022 - 01/2017
5	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2018 - 06/2011
4	NivolumabIBA 04/2024 - 10/2016
4	necitumumabIBA 12/2023 - 01/2019
4	B7-H1 AntigenIBA 02/2023 - 06/2018
4	RNA (Ribonucleic Acid)IBA 02/2023 - 01/2019
4	pembrolizumabIBA 01/2023 - 01/2021
4	Therapeutic UsesIBA 01/2023 - 09/2008
4	AntigensIBA 11/2022 - 01/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 04/2022 - 08/2004
4	SteroidsIBA 02/2021 - 06/2011
4	CytokinesIBA 03/2019 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2004
4	C-Reactive ProteinIBA 01/2018 - 09/2006
3	durvalumabIBA 04/2024 - 11/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 11/2013
3	Monoclonal AntibodiesIBA 01/2023 - 08/2004
3	CollagenIBA 11/2022 - 01/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 08/2020
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 11/2016
3	Immunoglobulin A (IgA)IBA 01/2022 - 06/2011
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 12/2013
3	AsbestosIBA 06/2021 - 01/2020
3	CrizotinibIBA 01/2021 - 01/2017
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2017
3	Peptides (Polypeptides)IBA 12/2017 - 09/2012
3	CreatinineIBA 01/2017 - 01/2013
3	Ligases (Synthetase)IBA 08/2016 - 01/2013
3	Morphine (MS Contin)FDA LinkGeneric 07/2016 - 11/2013
3	Ethanol (Ethyl Alcohol)IBA 01/2016 - 01/2012

Therapy/Procedure

52	Therapeutics 02/2024 - 01/2002
29	Drug Therapy (Chemotherapy) 04/2024 - 08/2004
17	Immunotherapy 04/2024 - 09/2006
6	Radiotherapy 04/2024 - 11/2011
6	Cardiac Rehabilitation 02/2015 - 12/2004
5	Chemoradiotherapy 04/2024 - 10/2006
4	Stents 01/2024 - 07/2002
3	Traction 03/2024 - 01/2013
3	Continuous Positive Airway Pressure 09/2023 - 01/2023
3	Renal Dialysis (Hemodialysis) 10/2022 - 01/2015
3	Extracorporeal Membrane Oxygenation 04/2022 - 01/2021
3	Catheters 09/2015 - 01/2007
3	Percutaneous Coronary Intervention 05/2011 - 08/2004